372 related articles for article (PubMed ID: 18288108)
1. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Chen KM; Harjes E; Gross PJ; Fahmy A; Lu Y; Shindo K; Harris RS; Matsuo H
Nature; 2008 Mar; 452(7183):116-9. PubMed ID: 18288108
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
3. An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.
Harjes E; Gross PJ; Chen KM; Lu Y; Shindo K; Nowarski R; Gross JD; Kotler M; Harris RS; Matsuo H
J Mol Biol; 2009 Jun; 389(5):819-32. PubMed ID: 19389408
[TBL] [Abstract][Full Text] [Related]
4. Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity.
Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2009; (53):87-8. PubMed ID: 19749273
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B; Cen S; Jiang JD
Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
[TBL] [Abstract][Full Text] [Related]
8. Dissecting APOBEC3G substrate specificity by nucleoside analog interference.
Rausch JW; Chelico L; Goodman MF; Le Grice SF
J Biol Chem; 2009 Mar; 284(11):7047-58. PubMed ID: 19136562
[TBL] [Abstract][Full Text] [Related]
9. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
10. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
[TBL] [Abstract][Full Text] [Related]
12. Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex.
Zhang S; Zhong L; Chen B; Pan T; Zhang X; Liang L; Li Q; Zhang Z; Chen H; Zhou J; Luo H; Zhang H; Bai C
Antiviral Res; 2015 Oct; 122():20-7. PubMed ID: 26241003
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
Kouno T; Luengas EM; Shigematsu M; Shandilya SM; Zhang J; Chen L; Hara M; Schiffer CA; Harris RS; Matsuo H
Nat Struct Mol Biol; 2015 Jun; 22(6):485-91. PubMed ID: 25984970
[TBL] [Abstract][Full Text] [Related]
14. NMR assignments and the identification of the secondary structure of the anti-retroviral cytidine deaminase.
Furukawa A; Nagata T; Habu Y; Sugiyama R; Hayashi F; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2008; (52):183-4. PubMed ID: 18776314
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
16. Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G.
Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
EMBO J; 2009 Feb; 28(4):440-51. PubMed ID: 19153609
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
Shandilya SM; Nalam MN; Nalivaika EA; Gross PJ; Valesano JC; Shindo K; Li M; Munson M; Royer WE; Harjes E; Kono T; Matsuo H; Harris RS; Somasundaran M; Schiffer CA
Structure; 2010 Jan; 18(1):28-38. PubMed ID: 20152150
[TBL] [Abstract][Full Text] [Related]
18. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
19. Model structure of human APOBEC3G.
Zhang KL; Mangeat B; Ortiz M; Zoete V; Trono D; Telenti A; Michielin O
PLoS One; 2007 Apr; 2(4):e378. PubMed ID: 17440614
[TBL] [Abstract][Full Text] [Related]
20. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
